Ornella Conort

664 total citations
23 papers, 478 citations indexed

About

Ornella Conort is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Ornella Conort has authored 23 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Geriatrics and Gerontology, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Economics and Econometrics. Recurrent topics in Ornella Conort's work include Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmaceutical studies and practices (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Ornella Conort is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmaceutical studies and practices (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Ornella Conort collaborates with scholars based in France, United States and Spain. Ornella Conort's co-authors include Pierrick Bedouch, B. Charpiat, M. Juste, Benoît Allenet, R. Roubille, Sébastien Chanoine, Anna Moltó, Thi Ha Vo, Maxime Dougados and Christian Roux and has published in prestigious journals such as Gastroenterology, Annals of the Rheumatic Diseases and Clinical Pharmacology & Therapeutics.

In The Last Decade

Ornella Conort

23 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ornella Conort France	10	325	140	133	111	98	23	478
James Gallagher Ireland	11	306 0.9×	73 0.5×	118 0.9×	146 1.3×	23 0.2×	23	553
H. Hamilton Ireland	9	373 1.1×	83 0.6×	51 0.4×	196 1.8×	76 0.8×	11	850
O. Conort France	8	238 0.7×	67 0.5×	69 0.5×	49 0.4×	11 0.1×	40	315
Ahmed Y. Mayet Saudi Arabia	12	211 0.6×	64 0.5×	141 1.1×	26 0.2×	11 0.1×	25	477
Dominik Rottenkolber Germany	7	158 0.5×	90 0.6×	45 0.3×	58 0.5×	14 0.1×	9	293
Just Ebbesen Norway	5	222 0.7×	105 0.8×	63 0.5×	67 0.6×	7 0.1×	9	426
Tobias Egger Germany	6	196 0.6×	252 1.8×	62 0.5×	64 0.6×	10 0.1×	8	403
J. Russell May United States	9	158 0.5×	100 0.7×	34 0.3×	100 0.9×	24 0.2×	25	425
Magalie Baudrant France	10	123 0.4×	52 0.4×	44 0.3×	30 0.3×	22 0.2×	26	301
Victor J B Huiskes Netherlands	8	189 0.6×	80 0.6×	37 0.3×	151 1.4×	81 0.8×	21	333

Countries citing papers authored by Ornella Conort

Since Specialization

Citations

This map shows the geographic impact of Ornella Conort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ornella Conort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ornella Conort more than expected).

Fields of papers citing papers by Ornella Conort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ornella Conort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ornella Conort. The network helps show where Ornella Conort may publish in the future.

Co-authorship network of co-authors of Ornella Conort

This figure shows the co-authorship network connecting the top 25 collaborators of Ornella Conort. A scholar is included among the top collaborators of Ornella Conort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ornella Conort. Ornella Conort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Charpiat, B., et al.. (2023). Traduction et adaptation au contexte hospitalier français d’un outil de codification des erreurs de prescription liées aux logiciels. Annales Pharmaceutiques Françaises. 81(6). 1054–1071. 1 indexed citations

Avouac, Jérôme, Claire Goulvestre, Anna Moltó, et al.. (2022). Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practice. Seminars in Arthritis and Rheumatism. 52. 151951–151951. 3 indexed citations

Mongaret, Céline, Sébastien Chanoine, Pierrick Bedouch, et al.. (2022). Using national data to describe characteristics and determine acceptance factors of pharmacists’ interventions: a six-year longitudinal study. International Journal of Clinical Pharmacy. 45(2). 430–441. 6 indexed citations

Charpiat, B., et al.. (2021). Characteristics of pharmacist’s interventions triggered by prescribing errors related to computerised physician order entry in French hospitals: a cross-sectional observational study. BMJ Open. 11(10). e045778–e045778. 5 indexed citations

López‐Medina, Clementina, et al.. (2021). Impact of a clinical pharmacist in a multidisciplinary consultation on the switch to a biosimilar for inflammatory rheumatic diseases. Joint Bone Spine. 89(3). 105322–105322. 4 indexed citations

Vo, Thi Ha, B. Charpiat, Sébastien Chanoine, et al.. (2021). CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists’ interventions. European Journal of Hospital Pharmacy. 28(4). 193–200. 39 indexed citations

Gutermann, Loriane, et al.. (2021). Impact of a pharmacist-led programme on biologics knowledge and adherence in patients with spondyloarthritis. Clinical and Experimental Rheumatology. 39(4). 811–818. 9 indexed citations

Moltó, Anna, Véred Abitbol, Loriane Gutermann, et al.. (2020). Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practice. Seminars in Arthritis and Rheumatism. 50(6). 1449–1456. 30 indexed citations

Moltó, Anna, Véred Abitbol, Loriane Gutermann, et al.. (2019). OP0227 EFFECTS OF SUCCESSIVE SWITCHES TO DIFFERENT BIOSIMILARS INFLIXIMAB ON IMMUNOGENICITY IN CHRONIC INFLAMMATORY DISEASES IN DAILY CLINICAL PRACTICE. Annals of the Rheumatic Diseases. 78. 190–191. 1 indexed citations

10.

Avouac, Jérôme, Anna Moltó, Véred Abitbol, et al.. (2017). Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France. Seminars in Arthritis and Rheumatism. 47(5). 741–748. 59 indexed citations

11.

Avouac, Jérôme, Anna Moltó, Marie Dior, et al.. (2017). Efficacy and Safety of Switching from Reference Infliximab to Biosimilar Infliximab in Patients with Inflammatory Bowel Disease: First French Experience. Gastroenterology. 152(5). S402–S402. 2 indexed citations

12.

Gutermann, Loriane, et al.. (2016). Conciliation médicamenteuse d’entrée en milieu hospitalier : intérêt du dossier pharmaceutique. Le Pharmacien Hospitalier et Clinicien. 51(1). 67–68. 1 indexed citations

13.

Vo, Thi Ha, B. Charpiat, M. Juste, et al.. (2015). Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review. Drug Safety. 39(2). 131–146. 29 indexed citations

14.

Conort, Ornella, et al.. (2011). Impact d’un programme d’éducation thérapeutique sur les connaissances, l’observance et la satisfaction des patients traités pour hépatite chronique virale C. Education thérapeutique du patient - Therapeutic patient education. 3(1). 21–33. 3 indexed citations

15.

Charpiat, B., Benoît Allenet, R. Roubille, et al.. (2008). Facteurs à prendre en considération pour la gestion des interactions médicamenteuses en pratique clinique. La Presse Médicale. 37(4). 654–664. 11 indexed citations

16.

Bouchand, Frédérique, et al.. (2007). Interventions pharmaceutiques avant et après informatisation de la prescription dans un service de médecine interne. La Presse Médicale. 36(3). 410–418. 20 indexed citations

17.

Allenet, Benoît, Pierrick Bedouch, R. Roubille, et al.. (2006). Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharmacy World & Science. 28(4). 181–188. 146 indexed citations

18.

Conort, Ornella, et al.. (2002). Intravenous to oral conversion of fluoroquinolones: knowledge versus clinical practice patterns.. Pharmacy World & Science. 24(2). 67–70. 9 indexed citations

19.

Conort, Ornella, Franck Mercier, Isabelle Madelaine, et al.. (2000). Multicenter study of the impact of prescription guidelines on the use of colony stimulating factors. Anti-Cancer Drugs. 11(2). 109–115. 3 indexed citations

20.

Dhôte, Robin, Jean‐François Bergmann, Olivier Chassany, et al.. (1995). Orocecal transit time in humans assessed by sulfapyridine appearance in saliva after sulfasalazine intake. Clinical Pharmacology & Therapeutics. 57(4). 461–470. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact